MAPT and Alzheimer disease: This study suggests that Alzheimer’s disease is characterized by the aggregation of amyloid-β in plaques, hyperphosphorylated tau in neurofibrillary tangles, and neuroinflammation, all of which contribute to neurodegeneration and cognitive decline.